4.6 Review

Transcriptional Response to Hypoxia: The Role of HIF-1-Associated Co-Regulators

Journal

CELLS
Volume 12, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/cells12050798

Keywords

hypoxia; HIF-1; transcriptional regulation; chromatin; cancer

Categories

Ask authors/readers for more resources

HIF-1 is a key regulator in cell survival under low oxygen conditions and its interaction with chromatin and transcriptional machinery is still being investigated. This review examines the co-regulators of HIF-1 and their impact on the expression of HIF-1 direct target genes in response to hypoxia, with the aim of identifying potential targets for anticancer therapy.
The Hypoxia Inducible Factor 1 (HIF-1) plays a major role in the cellular response to hypoxia by regulating the expression of many genes involved in adaptive processes that allow cell survival under low oxygen conditions. Adaptation to the hypoxic tumor micro-environment is also critical for cancer cell proliferation and therefore HIF-1 is also considered a valid therapeutical target. Despite the huge progress in understanding regulation of HIF-1 expression and activity by oxygen levels or oncogenic pathways, the way HIF-1 interacts with chromatin and the transcriptional machinery in order to activate its target genes is still a matter of intense investigation. Recent studies have identified several different HIF-1- and chromatin-associated co-regulators that play important roles in the general transcriptional activity of HIF-1, independent of its expression levels, as well as in the selection of binding sites, promoters and target genes, which, however, often depends on cellular context. We review here these co-regulators and examine their effect on the expression of a compilation of well-characterized HIF-1 direct target genes in order to assess the range of their involvement in the transcriptional response to hypoxia. Delineating the mode and the significance of the interaction between HIF-1 and its associated co-regulators may offer new attractive and specific targets for anticancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available